Cann American Corp. Share Price Other OTC
Equities
CNNA
US13764N2071
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 964K 80.51M |
---|---|---|---|---|---|
Net income 2022 | 10M 835M | Net income 2023 | 3M 251M | EV / Sales 2022 | - |
Net Debt 2022 | 202K 16.86M | Net Debt 2023 | 311K 25.98M | EV / Sales 2023 | - |
P/E ratio 2022 |
0.12
x | P/E ratio 2023 |
0.19
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 01/23/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 01/23/01 |
Pete Caruso
BRD | Director/Board Member | - | 01/23/01 |
Michael Kramer
BRD | Director/Board Member | - | 10/23/10 |
1st Jan change | Capi. | |
---|---|---|
+41.40% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.57% | 246B | |
-0.04% | 225B | |
+10.50% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |